Gunderson Capital Management Inc. Vertex Pharmaceuticals Inc Transaction History

Gunderson Capital Management Inc.

  • $236 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $817,896 - $1.09 Million
-3,951 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $107,373 - $127,302
420 Added 11.89%
3,951 $1.08 Million
Q2 2020

Aug 10, 2020
BUY
$225.48 - $295.8 $259,527 - $340,465
1,151 Added 48.36%
3,531 $1.03 Million
Q1 2020

May 12, 2020
BUY
$199.77 - $247.81 $475,452 - $589,787
2,380 New
2,380 $566,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gunderson Capital Management Inc. Portfolio

Follow Gunderson Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunderson Capital Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email